WallStreetZenWallStreetZen

NASDAQ: IONS
Ionis Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for IONS

Based on 9 analysts offering 12 month price targets for Ionis Pharmaceuticals Inc.
Min Forecast
$53.00+11.98%
Avg Forecast
$66.67+40.86%
Max Forecast
$82.00+73.25%

Should I buy or sell IONS stock?

Based on 9 analysts offering ratings for Ionis Pharmaceuticals Inc.
Strong Buy
Strong Buy
4 analysts 44.44%
Buy
3 analysts 33.33%
Hold
2 analysts 22.22%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IONS stock forecasts and price targets.

IONS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-07-16Find Out Why
lockedlocked$00.00+00.00%2024-07-16Find Out Why
lockedlocked$00.00+00.00%2024-06-27
lockedlocked$00.00+00.00%2024-06-03
lockedlocked$00.00+00.00%2024-05-08
Oppenheimer
Top 2%
99
BuyMaintains$75.00+58.46%2024-04-09
Piper Sandler
Bottom 6%
6
Strong BuyMaintains$63.00+33.11%2024-02-22
JP Morgan
Top 8%
93
HoldMaintains$55.00+16.21%2024-02-01
RBC Capital
Bottom 4%
4
BuyMaintains$70.00+47.90%2024-01-26

1 of 1

Forecast return on equity

Is IONS forecast to generate an efficient return?
Company
-6.79%
Industry
70.82%
Market
80.39%
IONS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IONS forecast to generate an efficient return on assets?
Company
-0.73%
Industry
30.66%
IONS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IONS earnings per share forecast

What is IONS's earnings per share in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
-$3.96
Avg 2 year Forecast
-$3.42
Avg 3 year Forecast
-$1.69

IONS revenue forecast

What is IONS's revenue in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$595.5M-23.32%
Avg 2 year Forecast
$743.7M-4.24%
Avg 3 year Forecast
$1.0B+34.36%
IONS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IONS revenue growth forecast

How is IONS forecast to perform vs Biotechnology companies and vs the US market?
Company
9.36%
Industry
64.53%
Market
11.29%
IONS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IONS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IONS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IONS$47.33$66.67+40.86%Strong Buy
HALO$54.30$59.83+10.19%Buy
JAZZ$108.84$185.42+70.36%Strong Buy
SMMT$9.75$13.50+38.46%Strong Buy
BPMC$113.46$117.69+3.73%Buy

Ionis Pharmaceuticals Stock Forecast FAQ

Is Ionis Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: IONS) stock is to Strong Buy IONS stock.

Out of 9 analysts, 4 (44.44%) are recommending IONS as a Strong Buy, 3 (33.33%) are recommending IONS as a Buy, 2 (22.22%) are recommending IONS as a Hold, 0 (0%) are recommending IONS as a Sell, and 0 (0%) are recommending IONS as a Strong Sell.

If you're new to stock investing, here's how to buy Ionis Pharmaceuticals stock.

What is IONS's earnings growth forecast for 2024-2026?

(NASDAQ: IONS) Ionis Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.72%.

Ionis Pharmaceuticals's earnings in 2024 is -$384,766,000.On average, 10 Wall Street analysts forecast IONS's earnings for 2024 to be -$577,584,985, with the lowest IONS earnings forecast at -$652,465,222, and the highest IONS earnings forecast at -$487,524,349. On average, 10 Wall Street analysts forecast IONS's earnings for 2025 to be -$498,763,683, with the lowest IONS earnings forecast at -$672,900,374, and the highest IONS earnings forecast at -$322,583,477.

In 2026, IONS is forecast to generate -$247,104,782 in earnings, with the lowest earnings forecast at -$405,783,740 and the highest earnings forecast at $235,004,252.

What is IONS's revenue growth forecast for 2024-2026?

(NASDAQ: IONS) Ionis Pharmaceuticals's forecast annual revenue growth rate of 9.36% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.29%.

Ionis Pharmaceuticals's revenue in 2024 is $776,620,000.On average, 9 Wall Street analysts forecast IONS's revenue for 2024 to be $86,929,386,555, with the lowest IONS revenue forecast at $79,241,682,237, and the highest IONS revenue forecast at $93,665,980,496. On average, 9 Wall Street analysts forecast IONS's revenue for 2025 to be $108,552,405,129, with the lowest IONS revenue forecast at $97,555,957,713, and the highest IONS revenue forecast at $126,655,614,674.

In 2026, IONS is forecast to generate $152,310,780,739 in revenue, with the lowest revenue forecast at $107,176,535,513 and the highest revenue forecast at $198,731,856,701.

What is IONS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: IONS) forecast ROA is -0.73%, which is lower than the forecast US Biotechnology industry average of 30.66%.

What is IONS's Price Target?

According to 9 Wall Street analysts that have issued a 1 year IONS price target, the average IONS price target is $66.67, with the highest IONS stock price forecast at $82.00 and the lowest IONS stock price forecast at $53.00.

On average, Wall Street analysts predict that Ionis Pharmaceuticals's share price could reach $66.67 by Jul 16, 2025. The average Ionis Pharmaceuticals stock price prediction forecasts a potential upside of 40.86% from the current IONS share price of $47.33.

What is IONS's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: IONS) Ionis Pharmaceuticals's current Earnings Per Share (EPS) is -$2.67. On average, analysts forecast that IONS's EPS will be -$3.96 for 2024, with the lowest EPS forecast at -$4.47, and the highest EPS forecast at -$3.34. On average, analysts forecast that IONS's EPS will be -$3.42 for 2025, with the lowest EPS forecast at -$4.61, and the highest EPS forecast at -$2.21. In 2026, IONS's EPS is forecast to hit -$1.69 (min: -$2.78, max: $1.61).

What is IONS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: IONS) forecast ROE is -6.79%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.